In summary, we developed a novel method by using the a single enantiomer ruthenium (II) complex to promote the self-assembly of the c-myc G-quadruplex DNA that could carry the gene into the nuclei of viable tumor cells. The gene discussed is MYC; the disease is neoplasm.